Acetylcholinesterase inhibitor, a current and long-used AD treatment, enhances all cholinergic signaling: fast, ionotropic nicotinic signal and slower, longer-lasting metabotropic muscarinic signal shown above (Fig. 5) and previously [68, 69]. Here, ACHE is linked to Alzheimer disease.